» Articles » PMID: 30809635

RAB14 Activates MAPK Signaling to Promote Bladder Tumorigenesis

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2019 Feb 28
PMID 30809635
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Bladder cancer (BC) is a fatal invasive malignancy accounting for approximately 5% of all cancer deaths in humans; however, the underlying molecular mechanisms and potential targeted therapeutics for BC patients remain unclear. We report herein that RAB14 was overexpressed in BC tissues and cells with high metastatic potential and its abundance was significantly associated with lymph node metastasis (P = 0.001), a high-grade tumor stage (P = 0.009), poor differentiation (P < 0.001) and unfavorable prognoses of BC patients (P = 0.003, log-rank test). Interference by RAB14 mediated a reduction in the TWIST1 protein and inhibited cell migration and invasion (P < 0.05). Moreover, silencing RAB14 reduced cell proliferation and induced apoptosis in vitro and suppressed tumorigenesis in a mouse xenograft model. We demonstrated that RAB14-promoted BC cancer development and progression were associated with activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase signaling through upregulation of MAPK1/MAPK8 and downregulation of dual-specificity protein phosphatase 6/Src homology 2 domain containing transforming protein/Fos proto-oncogene, AP-1 transcription factor subunit (FOS). We provide evidence that RAB14 acts as a tumor promoter and modulates the invasion and metastatic potential of BC cells via activating the MAPK pathway.

Citing Articles

A redox-related lncRNA signature in bladder cancer.

Zhao F, Xie H, Guan Y, Teng J, Li Z, Gao F Sci Rep. 2024; 14(1):28323.

PMID: 39550498 PMC: 11569154. DOI: 10.1038/s41598-024-80026-9.


DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery.

Lan W, Liao H, Chen Q, Zhu L, Pan Y, Chen Y Brief Bioinform. 2024; 25(3).

PMID: 38678587 PMC: 11056029. DOI: 10.1093/bib/bbae185.


RAB14 promotes epithelial-mesenchymal transition in bladder cancer through autophagy‑dependent AKT signaling pathway.

Deng H, Deng L, Chao H, Yu Z, Huang J, Song Z Cell Death Discov. 2023; 9(1):292.

PMID: 37558664 PMC: 10412633. DOI: 10.1038/s41420-023-01579-8.


MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells.

Phatak P, Burrows W, Creed T, Youssef M, Lee G, Donahue J BMC Cancer. 2022; 22(1):1265.

PMID: 36471277 PMC: 9721009. DOI: 10.1186/s12885-022-10304-0.


The role of long non-coding RNA HCG18 in cancer.

Wang Z, Ran R, Zhang S, Zhou W, Lv J, Ma C Clin Transl Oncol. 2022; 25(3):611-619.

PMID: 36346572 DOI: 10.1007/s12094-022-02992-8.